Caffeine intake linked to better vascular health in study
Medical Xpress - Cardiology
OCTOBER 8, 2024
Consuming more caffeine may improve heart health, according to a study published in the Rheumatology journal.
Tue.Oct 08, 2024
142 
Certain Arm Positions Can Lead to Inaccurate Blood Pressure Readings
Med Page Today
OCTOBER 8, 2024
(MedPage Today) -- Certain arm positions -- supported on a lap or hanging by the side of the body -- led to significant overestimation of blood pressure readings compared with standardized positioning, a randomized trial in JAMA Internal Medicine.
How terrible can it be to fail to recognize OMI? To whom is OMI Obvious or Not Obvious?
Dr. Smith's ECG Blog
OCTOBER 8, 2024
This was sent to me by a reader who wishes to remain anonymous. A lady in her 60s came to the ER with chest discomfort and shortness of breath. She had a history of previous anterior MI treated by primary PCI to the proximal LAD. The first EKG is from 2:30 PM on the day of presentation to the ER. Smith : To me this is a blatantly obvious acute anterior OMI.
Time-Restricted Eating Shows Promise for Metabolic Syndrome in 3-Month Trial
HCPLive
OCTOBER 8, 2024
Time-restricted eating, even without calorie restriction, improved glycemic control and cardiometabolic health in patients with metabolic syndrome.
Bridging Innovation & Patient Care: The Growing Role of AI
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Dual-Antiplatelet Therapy After Drug-Eluting Stenting in ACS
JAMA Cardiology
OCTOBER 8, 2024
This systematic review and network meta-analysis investigates the optimal duration of dual antiplatelet therapy in patients with acute coronary syndromes (ACS) undergoing percutaneous coronary intervention with drug-eluting stents.
Unmet Needs, Future Research in Schizophrenia and Muscarinic Agonists
HCPLive
OCTOBER 8, 2024
In part 5 of 5, experts discuss ongoing unmet needs and future research priorities in schizophrenia management.
Sign up to get articles personalized to your interests!
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
More Trending
Social Determinants of Health Shape Pain Outcomes in Sickle Cell Disease
HCPLive
OCTOBER 8, 2024
Education and employment, social and emotional functioning, and healthcare access are notable factors influencing pain in sickle cell disease.
What Is the Optimal Hemoglobin Transfusion Threshold in Patients with Myocardial Infarction?
NEJM Journal Watch - Cardiology
OCTOBER 8, 2024
It's probably 9 g/dL in patients with MI and anemia.
FDA Grants Breakthrough Therapy Designation to Survodutide for Noncirrhotic MASH
HCPLive
OCTOBER 8, 2024
In addition to the Breakthrough Therapy Designation, Boehringer Ingelheim announced the initiation of 2 phase 3 trials in adults with MASH and fibrosis and compensated MASH cirrhosis.
Trial finds metabolic risk contributes to diabetes onset in people with HIV
Medical Xpress - Cardiology
OCTOBER 8, 2024
For people with HIV (PWH) with low-to-moderate atherosclerotic cardiovascular disease (ASCVD) risk, metabolic risk factors contribute to new-onset diabetes mellitus (DM) among those treated with pitavastatin or placebo, according to a study published online Oct. 8 in the Annals of Internal Medicine.
Renuka Jain, MD, FACC, Named Next BOG Chair-Elect
American College of Cardiology
OCTOBER 8, 2024
The ACC has named Renuka Jain, MD, FACC, as the incoming chair-elect of its Board of Governors, beginning April 2025 following ACC.25 in Chicago, IL. She will replace David E. Winchester, MD, MS, FACC, as BOG Chair for 2026 to 2027.
UMass hospital cuts heart failure readmissions in half
Becker's Hospital Review - Cardiology
OCTOBER 8, 2024
Southbridge, Mass.-based UMass Memorial Health-Harrington Hospital reduced the all-cause 30-day readmission for heart failure patients by 50% as part of a remote patient monitoring program with digital health company Brook Health.
Team-Based Care of Women With CVD From the Preconception Through Postpartum Periods: Optimizing Preconception Cardiometabolic Conditions
American College of Cardiology
OCTOBER 8, 2024
Cardiovascular disease (CVD) has been the leading cause of maternal death in the United States, with increasing rates over the past decades due to factors such as advancing age and increased CVD risk factors.
Embracing New Therapies in Schizophrenia Management: Introductions
HCPLive
OCTOBER 8, 2024
In part 1 of 5, panel moderator gives an overview of the Special Report focusing on the approval of Xanomeline and tropism chloride capsules for schizophrenia.
Chronic Use of Amiodarone Against Implantable Cardioverter-Defibrillator Therapy for Primary Prevention of Death in Patients With Chagas Cardiomyopathy Study
American College of Cardiology
OCTOBER 8, 2024
The goal of the CHAGASICS trial was to evaluate implantable cardioverter-defibrillators (ICDs) compared with amiodarone among patients with chronic Chagas cardiomyopathy.
Allergy Month in Review: September 2024
HCPLive
OCTOBER 8, 2024
In the allergy news space, this Month in Review highlights some of the most significant stories covered by the editorial team.
Prime Locations for AEDs; Fluctuating Lp(a); Formalized Telestroke Training?
Med Page Today
OCTOBER 8, 2024
(MedPage Today) -- A study in Taiwan suggested that public automated external defibrillators (AEDs) are optimally located near bus stops and convenience stores. (Journal of the American Heart Association) Many people experienced clinically significant.
FDA Issues Second CRL for Dasiglucagon (Zegalogue) in Congenital Hyperinsulinism
HCPLive
OCTOBER 8, 2024
The FDA's decision to issue a CRL was announced on October 08, 2024 and cites issues with the timing of the facility inspection.
WVU Medicine opens '1-stop-shop' cardiometabolic clinic
Becker's Hospital Review - Cardiology
OCTOBER 8, 2024
Morgantown, W.Va.-based WVU Medicine has opened the first cardiometabolic clinic in West Virginia to provide more streamlined care for patients with heart disease and metabolic conditions.
CHEST 2024: Ensifentrine Improves Lung Function, Quality of Life Regardless of COPD Severity
HCPLive
OCTOBER 8, 2024
New research presented at CHEST 2024 highlights ensifentrine’s effectiveness in improving lung function, symptoms, and quality of life for COPD patients, regardless of disease severity.
Older Patients With NSTEMI Randomized Interventional Treatment: SENIOR-RITA Trial
American College of Cardiology
OCTOBER 8, 2024
In this interview, Drs. Nanette Kass Wenger and Vijay Kunadian discuss the SENIOR RITA trial results and the importance of individualizing routine invasive therapy in individuals ≥75 years of age.
Gerald Maguire, MD: The Future of Acetylcholine and Muscarinic Receptors
HCPLive
OCTOBER 8, 2024
HCPLive spoke with Maguire about the benefits of acetylcholine and muscarinic receptors for the treatment of schizophrenia.
The relationship between repeated measurements of HbA1c and risk of coronary events among the common haptoglobin phenotype groups: the Action for Health in Diabetes (Look AHEAD) study
Cardiovascular Diabetology
OCTOBER 8, 2024
In the ACCORD study, participants with the haptoglobin (Hp) 2–2 phenotype and glycated hemoglobin (HbA1c) ≥ 8.0% had a higher risk of coronary artery disease (CAD) compared to those with HbA1c 7.0–7.9%.
Balancing the Benefits and Risks of Xanomeline and Trospium Chloride Capsules
HCPLive
OCTOBER 8, 2024
In part 4 of 5, experts discuss medication adherence to schizophrenia treatments, particularly of xanomeline and trospium choloride capsules for schizophrenia.
External validation and calibration of risk equations for prediction of diabetic kidney diseases among patients with type 2 diabetes in Taiwan
Cardiovascular Diabetology
OCTOBER 8, 2024
Most existing risk equations for predicting/stratifying individual diabetic kidney disease (DKD) risks were developed using relatively dated data from selective and homogeneous trial populations comprising pre.
Ixekizumab as Effective, if not More Effective as TNFi, JAKi, IL-12/23i for PsA Treatment
HCPLive
OCTOBER 8, 2024
An interim analysis of the PRO-SPIRIT study compared outcomes at 3 months after starting new treatments for psoriatic arthritis.
Report of a giant invasive, wall-penetrating cardiac lipoma
Journal of Cardiothoracic Surgery
OCTOBER 8, 2024
Cardiac lipoma, a seldom-encountered benign tumor positioned beneath the endocardium, has the potential to impair electrophysiological functions. Diagnosis is principally based on imaging modalities. The uniqu.
Early diaphragm dysfunction assessed by ultrasonography after cardiac surgery: a retrospective cohort study
Frontiers in Cardiovascular Medicine
OCTOBER 8, 2024
ObjectiveApproximately 10%–70% of patients may develop diaphragmatic dysfunction after cardiac surgery, which may lead to delayed weaning from mechanical ventilation, increased ICU stays, postoperative hospitalization stays, and respiratory complications. However, its impact on prognosis and risk factors remain controversy. Therefore, we conducted a retrospective cohort study in which we evaluated diaphragmatic dysfunction in patients who underwent cardiac surgery via bedside diaphragm ultrasoun
Blue Shield California Offers Adalimumab Biosimilar for a Quarter of Reference Price
HCPLive
OCTOBER 8, 2024
BSC and Fresnius Kabi reached a deal facilitated by Evio Pharmacy Solutions by sidestepping pharmacy benefit managers.
Totally 3D endoscopic aortic valve replacement: initial results and experience from a single center
Frontiers in Cardiovascular Medicine
OCTOBER 8, 2024
ObjectiveThis study aimed to evaluate the feasibility and initial outcomes of totally endoscopic aortic valve replacement (TEAVR) performed via a single working port at the fourth intercostal space (ICS) utilizing a 3D endoscopic system.MethodsA retrospective observational study was conducted on 35 consecutive patients who underwent TEAVR over a six-month period from December 2023 to June 2024.
Pulmonology Month in Review: September 2024
HCPLive
OCTOBER 8, 2024
This Month in Review article featured a variety of notable updates in the field of pulmonology covered in September 2024.
Case Report: Multimodality imaging of a bronchogenic cyst in the interatrial septum
Frontiers in Cardiovascular Medicine
OCTOBER 8, 2024
Intracardiac bronchogenic cysts (IBCs) are very rare. To date, only a few cases of IBC have been reported in the literature. We report a case of a bronchogenic cyst that arose from the interatrial septum in a 42-year-old man who presented with symptoms of palpitation. A unilocular cystic lesion of the heart was found initially on echocardiography and subsequently on computed tomography and magnetic resonance imaging.
Ophthalmology Month in Review: September 2024
HCPLive
OCTOBER 8, 2024
This September 2024 month in review highlights recent advances in gene therapies and therapies demonstrating the potential for improved vision outcomes.
Amlexanox reduces new-onset atrial fibrillation risk in sepsis by downregulating S100A12: a Mendelian randomization study
Frontiers in Cardiovascular Medicine
OCTOBER 8, 2024
BackgroundSepsis is characterized by high morbidity and mortality rates, alongside limited therapeutic efficacy. Atrial fibrillation (AF), the most common arrhythmia, has been closely linked to sepsis in prior research. However, the specific mechanisms through which sepsis leads to new-onset AF remain poorly understood. This study focuses on identifying critical genes that are dysregulated in the development of new-onset AF within the context of sepsis, with the goal of uncovering new potential
Mechanism of Action of Xanomeline and Trospium Chloride Capsules in Schizophrenia
HCPLive
OCTOBER 8, 2024
In part 2 of 5, experts discuss the unique mechanism of xanomeline and trospium choloride capsules for the treatment of schizozphrenia.
Impact of admission glucose and 30-day major adverse cardiovascular events on patients with chest pain in an emergency setting: insights from the China EMPACT registry
Frontiers in Cardiovascular Medicine
OCTOBER 8, 2024
ObjectiveAlthough the association between admission glucose (AG) and major adverse cardiac events (MACE) is well-documented, its relationship with 30-day MACE in patients presenting with cardiac chest pain remains unclarified. In light of this, this study aims to examine the correlation between AG levels and the incidence of MACE in patients with chest pain in an emergency setting.Materials and methodsWe consecutively enrolled patients who presented to the emergency department for chest pain sym
Let's personalize your content